A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(7 sites)

China

Peking Union Medical College Hospital, Beijing

Nanfang Hospital Southern Medical University, Guangzhou

Jinan Central Hospital, Jihan

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

The First Affiliated Hospital of Soochow University, Suzhou

Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin

Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan